Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin With or Without Mechanical Compression Devices for VTE Prophylaxis After Knee or Hip Arthroplasty
NCT03027167Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of aspirin in venous thromboembolism (VTE), sponsored by Washington University School of Medicine. Planned start Jan 2017; status: withdrawn.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03027167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027167.